Ticker: MRK | Published: 2026-09-22
Pipeline Wins Lift MRK
Merck is rallying moderately as European regulators backed the Keytruda-Padcev combo in bladder cancer and the FDA updated Winrevair's label with strong risk-reduction data, adding fresh regulatory momentum on top of a broadly rising market.
Sources: https://finance.yahoo.com/healthcare/articles/merck-gets-chmp-backing-keytruda-152700693.html, https://www.s